Advancing Integrative Care
.
Improving Patient Outcomes
Supporting Practice Success
/ Most Recent /
Physical Activity Anytime During Adulthood Protects Cognition
Numerous studies show that regular physical activity helps ward off dementia and other neurological problems. Now a study in the ...
Spring Clean Your Microbiota: Trillions of Tiny Lives That Influence Your Health
Emerging research suggests that the microbiota influences many aspects of wellbeing, far beyond digestive and immune health. Nurturing these trillions of tiny lives requires a ...
Omega-3s Protect Against Severe Covid
People who consume more omega-3 fatty acids — particularly EPA and DHA — are less likely to suffer from severe ...
Nitrates from Water May Raise Prostate Cancer Risk
Nitrates from tap and bottled water may play a role in prostate cancer, says a new study in Environmental Health ...
Vitamin E Alleviates Postmenopausal Insomnia
According to a double-blind, placebo-controlled trial in Nutrients, vitamin E was shown to help alleviate chronic insomnia disorder and enhance ...
Zonulin: A Key to Understanding Leaky Gut & Certain Diseases
Over the past 15 years, a growing body of published research supports the hypothesis that the protein zonulin is a ...
Sleep: Your Night Job
Any health news junkie can see that the importance of sleep has come to center stage. Our collective interest in ...
Bacillus Probiotic Helps Eliminate Staph in the Gut
One particular probiotic strain found in supplements — Bacillus subtilis — was shown to dramatically reduce Staphylococcus aureus (S. aureus) ...
To Help Patients Stop Smoking, Think CBD
For patients who struggle to quit smoking, there is a promising new natural solution — CBD. According to a study ...
/ Top Articles /
Sorry, we couldn't find any posts. Please try a different search.
/ Weight Loss /
Stopping GLP-1 Receptor Agonists… Why and How to Plan an “Exit Strategy” for Your Patients
In recent years, the pharmaceutical landscape has seen the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) such as semaglutide and tirzepatide, offering promising outcomes in weight reduction for those struggling with obesity. Landmark trials demonstrated significant weight loss in obese individuals. ...
Acknowledging Gender Differences in Obesity Research
With the celebration of International Women’s Day on March 8th, it’s timely to review the differences in women’s health research and how that specifically affects investigations into treatments for overweight and obesity. Obesity and overweight—gender similarities and differences By 2022, 8 billion ...
Researchers Link Abdominal Fat to Brain Health in Men
According to the World Health Organization, some 55 million people globally suffer from Alzheimer’s disease or dementia. With 10 million new cases diagnosed annually, dementia has become the seventh leading cause of death worldwide, and those numbers are only likely to grow ...
Amarasate, An Extract of Bitter Hop Flowers Shown Effective For Weight Loss: The Science And Mode Of Action
With the massive interest in the use of glucagon-like peptide-1 (GLP-1) receptor agonists for the management of both Type 2 diabetes and obesity/overweight, it is timely to review the mode of action of these medications and that of an alternative GLP-1-stimulating nutraceutical. ...
Multiple Human Studies Show Significant Weight-Loss Benefits for Amarasate, A Proprietary Extract of Bitter Hops
A trio of studies performed in the past 5 years shows that a proprietary hops extract called Amarasate can help curb hunger and food cravings.